Lv3
270 积分 2021-04-21 加入
Clinical Trials with Oncolytic Adenovirus in China
6天前
已完结
Per-Protocol Analyses of Pragmatic Trials
9天前
已完结
CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma
10天前
已完结
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
13天前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
14天前
已完结
Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells
20天前
已完结
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments
23天前
已完结
A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
23天前
已完结
An oncolytic virus–T cell chimera for cancer immunotherapy
27天前
已完结
Genetic engineering of systemically injectable oncolytic viruses for pyroptosis-accelerated cancer virotherapy
28天前
已完结
皖公网安备34019202002308
